Skip Navigation

A Phase II Trial of HER2-Targeted Therapies for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Brief Summary

Type:
Head and Neck Cancers

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05408845

Study #:
STUDY00161816

Start Date:
Aug 15, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05408845

View Complete Trial Details & Eligibility at ClinicalTrials.gov